Chief Business Officer
“Our robust TCR discovery platform generates opportunities for TScan to develop a proprietary pipeline of TCR therapies as well as to collaborate with select partners.”
Henry Rath is the Chief Business Officer at TScan Therapeutics. Henry has over 25 years of experience in the biotechnology industry with roles spanning corporate finance, strategy, and business development. Prior to joining TScan, Henry worked at Seres Therapeutics Inc., Amgen Inc., Catabasis Pharmaceuticals Inc., and Baxter Bioscience. Mr. Rath has completed numerous in- and out-licensing transactions as well as mergers and acquisitions in the United States as well as internationally. Mr. Rath began his career with roles in the banking and consulting industries focusing on biotechnology with Oppenheimer & Co. Inc. and LEK Consulting. Mr. Rath earned his undergraduate degree from Harvard College and his M.B.A. from the Wharton School of the University of Pennsylvania.
When he’s not advancing the ball with TScan’s corporate partners, Henry coaches girls’ soccer.